Free Trial
Louise Chen

Louise Chen Analyst Performance

Managing Director at Scotiabank

Louise Chen is a stock analyst at Scotiabank focused in the healthcare sector, covering 44 publicly traded companies. Over the past year, Louise Chen has issued 16 stock ratings, including buy and hold recommendations. While full access to Louise Chen's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Louise Chen's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
336 Last 11 Years
Buy Recommendations
94.59% 315 Buy Ratings
Companies Covered
44 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy94.6%315 ratings
Hold5.4%18 ratings
Sell0.0%0 ratings

Out of 333 total stock ratings issued by Louise Chen at Scotiabank, the majority (94.6%) have been Buy recommendations, followed by 5.4% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
72.7% of companies on NASDAQ
32 companies
NYSE
22.7% of companies on NYSE
10 companies
NYSEAMERICAN
2.3% of companies on NYSEAMERICAN
1 company
OTCMKTS
2.3% of companies on OTCMKTS
1 company

Louise Chen, an analyst at Scotiabank, currently covers 44 companies listed on NASDAQ, NYSE, NYSEAMERICAN and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
43 companies
97.7%
Finance
1 company
2.3%

Louise Chen of Scotiabank specializes in stock coverage within the Healthcare sector, with additional focus on Finance companies.

Coverage Industries

IndustryPercentage
PHARMACEUTICALS
25 companies
56.8%
BIOTECHNOLOGY
17 companies
38.6%
CAPITAL MARKETS
1 company
2.3%
HEALTHCARE PROVIDERS & SERVICES
1 company
2.3%

Louise Chen's Ratings History at Scotiabank

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Pfizer Inc. stock logo
PFE
Pfizer
10/6/2026Boost Price Target$27.44$33.00Outperform
AbbVie Inc. stock logo
ABBV
AbbVie
10/6/2026Boost Price Target$263.24$320.00Outperform
AbbVie Inc. stock logo
ABBV
AbbVie
10/6/2026Boost Price Target$265.93$320.00Sector Outperform
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
9/29/2026Boost Price Target$146.57$180.00Sector Outperform
Amgen Inc. stock logo
AMGN
Amgen
9/28/2026Boost Price Target$417.79$500.00Outperform
Amgen Inc. stock logo
AMGN
Amgen
8/5/2026Boost Price Target$406.07$450.00Outperform
Amgen Inc. stock logo
AMGN
Amgen
8/5/2026Boost Price Target$406.14$450.00Sector Outperform
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
6/30/2026Boost Price Target$127.03$155.00Sector Outperform
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/13/2026Boost Price Target$496.69$558.00Outperform
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
1/29/2026Boost Price Target$32.43$40.00Sector Outperform
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
1/22/2026Reiterated Rating$219.71Outperform
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
1/22/2026Boost Price Target$219.87$265.00Sector Outperform
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
1/9/2026Reiterated Rating$55.65$60.00Sector Perform
Teva Pharmaceutical Industries Ltd. stock logo
TEVA
Teva Pharmaceutical Industries
12/5/2025Initiated Coverage$28.39$35.00Sector Outperform
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
12/4/2025Boost Price Target$101.29$120.00Sector Outperform
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
11/24/2025Boost Price Target$770.08$770.00Sector Perform
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
3/7/2025Initiated Coverage$10.79$30.00Sector Outperform
Avidity Biosciences, Inc. stock logo
RNA
Avidity Biosciences
3/7/2025Initiated Coverage$30.35$70.00Sector Outperform
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
3/7/2025Initiated Coverage$7.41$17.00Sector Outperform
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
3/7/2025Initiated Coverage$12.24$50.00Sector Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
3/7/2025Initiated Coverage$28.13$50.00Sector Outperform
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3/7/2025Initiated Coverage$2.70$15.00Sector Outperform
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
3/7/2025Initiated Coverage$35.39$55.00Sector Outperform
Gain Therapeutics, Inc. stock logo
GANX
Gain Therapeutics
3/7/2025Initiated Coverage$1.80$12.00Sector Outperform
Innoviva, Inc. stock logo
INVA
Innoviva
3/7/2025Initiated Coverage$17.59$55.00Sector Outperform
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
3/7/2025Initiated Coverage$23.94$50.00Sector Outperform
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
3/7/2025Initiated Coverage$52.80$55.00Sector Perform
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
3/7/2025Initiated Coverage$103.03$105.00Sector Perform
Ardelyx, Inc. stock logo
ARDX
Ardelyx
3/7/2025Initiated Coverage$5.30$15.00Sector Outperform
Aclaris Therapeutics, Inc. stock logo
ACRS
Aclaris Therapeutics
3/7/2025Initiated Coverage$1.83$15.00Sector Outperform